Crossmark

Identification of m6A suppressor EIF4A3 as a novel cancer prognostic and immunotherapy biomarker through bladder cancer clinical data validation and pan-cancer analysis

Crossref DOI link: https://doi.org/10.1038/s41598-023-43500-4

Published Online: 2023-09-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yan, Huaqing

Zhang, Liqi

Li, Rubing
Funding

Funding for this research was provided by:

The Natural Science Foundation of Ningbo (2022J259, 2023J145)
License Information

Text and Data Mining valid from 2023-09-30

Version of Record valid from 2023-09-30
More Information

Article History

Received: 13 July 2023

Accepted: 25 September 2023

First Online: 30 September 2023

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below